Skip to main content

Table 1 Demographic and clinical features of patients with and without cognitive deficit at PML diagnosis

From: The still under-investigated role of cognitive deficits in PML diagnosis

  Cognitive onset No cognitive onset  
n = 13 n = 15 Significance
Gender (♂)a 7 (53.8%) 14 (93.3%) 0.016*
Age at MS diagnosisb 25.6 (11.5) 23.3 (10.3) 0.414
Age at PML diagnosisb 39.0 (14.1) 37.5 (13.8) 0.584
MS duration (years)b 12.9 (7.3) 12.0 (9.6) 0.740
Number of infusions b 33.0 (19.5) 34.5 (20.0) 0.856
Prior Immunesoppressiona 5 (34.7%) 4 (29.4%) 0.505
Viral Loadc 324 [12–26300] 64 [11–4403] 0.271
IRIS insurgence (yes)a 11 (84.6%) 8 (53.3%) 0.077
Steroids administration (yes)a 12 (92.3%) 14 (93.3%) 0.912
Other therapies (yes)a 8 (61.5%) 10 (66.6%) 0.825
PLEX (yes)a 11 (84.6%) 8 (53.3%) 0.077
  1. Number denotes row number (a), mean (standard deviation) (b) and median [range] (c). Statistical significance was evaluated using Chi Square (a), two independent samples t test (b) and Mann Whitney test (c). *asterisk denotes statistical significance